Clinical Trial Update: XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study

View source ↗

Summary

A post-approval, single-arm clinical trial in China evaluating XIENCE V Everolimus Eluting Coronary Stent System (EECSS) with completed status and results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioplasty-related Conditions
• Coronary Artery Disease
• Coronary Disease
• Coronary Restenosis
• Coronary Stenosis
• Myocardial Ischemia
• Stent Thrombosis
• Vascular Disease

Drugs mentioned

• XIENCE V Everolimus-Eluting Coronary Stent System (EECSS) (everolimus-eluting coronary stent)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Angioplasty, Chronic Coronary Occlusion | Status: COMPLETED | Results posted: 2019-03-01